| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
GpIIbIIIa| 1 | 2008 | Chemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: A review. | 
| + | - | nl | Exp Clin Cardiol 13(4):192-7 (2008) |
| 2 | 2006 | Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. |
| + | - | nl | J Thromb Haemost 4(3):678-9 (2006) |
| 3 | 2008 | The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. |
| + | - | nl | Blood 112(8):3011-25 (2008) |
| 4 | 2009 | Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. |
| + | - | nl | Eur Heart J 30(22):2705-13 (2009) |
| 5 | 2008 | Platelet glycoprotein IIb/IIIa receptor inhibitors--end of an era? |
| + | - | nl | Eur Heart J 29(4):429-31 (2008) Roffi M |
| 6 | 2003 | Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment. |
| + | - | nl | Heart 89(5):535-7 (2003) Brown DL |
| 7 | 1998 | The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine. |
| + | - | nl | Jpn Circ J 62(4):233-43 (1998) |
| 8 | 2000 | A critical appraisal of platelet glycoprotein IIb/IIIa inhibition. |
| + | - | nl | J Am Coll Cardiol 36(7):2028-35 (2000) |
| 9 | 2009 | Glycoprotein IIb/IIIa inhibitors in clinical practice. | 
| + | - | nl | Arq Bras Cardiol 92(1):68-76 (2009) |
